Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Physiol ; 581(Pt 3): 1323-32, 2007 Jun 15.
Article in English | MEDLINE | ID: mdl-17430988

ABSTRACT

In pregnant women with type 1 diabetes, suboptimal glucose control in the first trimester is a strong predictor for giving birth to a large fetus. However, the mechanisms underlying this association are unknown. We hypothesized that transient hyperglycaemia in early pregnancy results in (1) increased placental growth and (2) an up-regulation of placental nutrient transport capacity, which leads to fetal overgrowth at term. In order to test this hypothesis, pregnant rats were given intraperitoneal injections of glucose (2 g kg(-1), resulting in a 50-100% increase in blood glucose level during 90 min) or saline (control) in either early or late gestation using four different protocols: one single injection on gestational day (GD) 10 (n=5), three injections on GD 10 (n=8-9), six injections on GD 10 and 11 (n=9-11) or three injections on GD 19 (n=7-8). Multiple injections were given approximately 4 h apart. Subsequently, animals were studied on GD 21. Three glucose injections in early pregnancy significantly increased placental weight by 10%, whereas fetal weight was found to be increased at term in response to both three (9% increase in fetal weight, P<0.05) and six glucose injections (7%, P=0.05) in early gestation. A single glucose injection on GD 10 or three injections of glucose on GD 19 had no effect on placental or fetal growth. In groups where a change in feto-placental growth was observed, we measured placental system A and glucose transport activity in the awake animals on GD 21 and placental expression of the glucose and amino acid transporters GLUT1, GLUT3, SNAT2 (system A), LAT1 and LAT 2 (system L). Placental system A transport at term was down-regulated by six glucose injections in early pregnancy (by -33%, P<0.05), whereas placental mRNA and protein levels were unchanged. No long-term alterations in maternal metabolic status were detected. In conclusion, we demonstrate that transient hyperglycaemia in early pregnancy is sufficient to increase fetal weight close to term. In contrast, brief hyperglycaemia in late pregnancy did not stimulate fetal growth. Increased fetal growth may be explained by a larger placenta, which would allow for more nutrients to be transferred to the fetus. These data suggest that maternal metabolic control in early pregnancy is an important determinant for feto-placental growth and placental function throughout the remainder of gestation. We speculate that maternal metabolism in early pregnancy represents a key environmental cue to which the placenta responds in order to match fetal growth rate with the available resources of the mother.


Subject(s)
Amino Acid Transport Systems, Neutral/metabolism , Diabetes, Gestational/metabolism , Fetal Nutrition Disorders/etiology , Fetal Weight , Glucose Transport Proteins, Facilitative/metabolism , Hyperglycemia/metabolism , Maternal-Fetal Exchange , Placenta/metabolism , Amino Acid Transport System A , Amino Acid Transport System y+/metabolism , Amino Acid Transport Systems/metabolism , Amino Acid Transport Systems, Neutral/genetics , Animals , Blood Glucose/metabolism , Diabetes, Gestational/blood , Diabetes, Gestational/chemically induced , Diabetes, Gestational/pathology , Disease Models, Animal , Female , Fetal Nutrition Disorders/blood , Fetal Nutrition Disorders/metabolism , Fetal Nutrition Disorders/pathology , Fusion Regulatory Protein 1, Light Chains/metabolism , Gestational Age , Glucose , Glucose Transport Proteins, Facilitative/genetics , Glucose Transporter Type 1/metabolism , Glucose Transporter Type 3/metabolism , Hyperglycemia/blood , Hyperglycemia/chemically induced , Hyperglycemia/complications , Hyperglycemia/pathology , Insulin/blood , Large Neutral Amino Acid-Transporter 1/metabolism , Organ Size , Placenta/pathology , Pregnancy , RNA, Messenger/metabolism , Rats , Rats, Sprague-Dawley
2.
Mamm Genome ; 13(6): 302-9, 2002 Jun.
Article in English | MEDLINE | ID: mdl-12115033

ABSTRACT

The rat provides valuable and sometimes unique models of human complex diseases. To fully exploit the rat models in biomedical research, it is important to have access to detailed knowledge of the rat genome organization as well as its relation to the human genome. Rat Chromosome 10 (RNO10) harbors several important cancer-related genes. Deletions in the proximal part of RNO10 were repeatedly found in a rat model for endometrial cancer. To identify functional and positional candidate genes in the affected region, we used radiation hybrid (RH) mapping and single- and dual-color fluorescence in situ hybridization (FISH) techniques to construct a detailed chromosomal map of the proximal part of RNO10. The regional localization of 14 genes, most of them cancer-related ( Grin2a, Gspt1, Crebbp, Gfer, Tsc2, Tpsb1, Il9r, Il4, Irf1, Csf2, Sparc, Tp53, Thra1, Gh1), and of five microsatellite markers ( D10Mit10, D10Rat42, D10Rat50, D10Rat72, and D10Rat165) was determined on RNO10. For a fifteenth gene, Ppm1b, which had previously been assigned to RNO10, the map position was corrected to RNO6q12-q13.


Subject(s)
Radiation Hybrid Mapping , Animals , Humans , In Situ Hybridization, Fluorescence , Mice , Microsatellite Repeats , Molecular Sequence Data , Rats , Sequence Alignment , Sequence Analysis, DNA , Synteny
SELECTION OF CITATIONS
SEARCH DETAIL
...